TYSONS CORNER, VA, Jan. 13, 2017 — IBM‘s (NYSE: IBM) Watson Health unit has entered into a research initiative with the U.S.
Altimmune has received a potential five-year, $120.2 million contract from the Biomedical Advanced Research and Development Authority to conduct clinical
